| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.54B | 20.67B | 19.17B | 17.50B | 15.96B | 14.05B |
| Gross Profit | 11.58B | 12.20B | 11.54B | 10.94B | 9.68B | 8.44B |
| EBITDA | 2.63B | 3.19B | 2.86B | 2.59B | 2.31B | 1.73B |
| Net Income | 760.55M | 1.01B | 854.56M | 739.69M | 846.76M | 483.62M |
Balance Sheet | ||||||
| Total Assets | 17.83B | 18.96B | 18.03B | 15.69B | 14.57B | 11.51B |
| Cash, Cash Equivalents and Short-Term Investments | 8.49B | 8.94B | 8.46B | 6.66B | 6.68B | 5.04B |
| Total Debt | 3.17B | 2.70B | 3.02B | 2.01B | 1.96B | 693.48M |
| Total Liabilities | 8.55B | 8.61B | 8.54B | 7.03B | 6.62B | 4.36B |
| Stockholders Equity | 9.25B | 10.33B | 9.46B | 8.64B | 7.93B | 7.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.68B | 1.23B | 267.18M | 293.69M | 327.16M |
| Operating Cash Flow | 0.00 | 2.84B | 2.81B | 2.20B | 1.68B | 1.56B |
| Investing Cash Flow | 0.00 | -1.58B | -1.60B | -1.80B | -1.14B | -1.19B |
| Financing Cash Flow | 0.00 | -822.52M | 280.79M | -645.92M | 763.68M | -822.04M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥19.44B | 17.55 | ― | 0.90% | 17.75% | 44.95% | |
69 Neutral | ¥19.57B | 43.69 | ― | 2.13% | -0.62% | -11.36% | |
65 Neutral | ¥30.65B | 6.28 | 10.34% | 4.82% | -3.03% | 38.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥21.50B | 22.38 | ― | 1.50% | 7.83% | 49.73% | |
54 Neutral | ¥5.60B | 14.56 | ― | 1.04% | -3.46% | -59.98% | |
50 Neutral | ¥1.53B | -2.58 | ― | ― | 5.17% | ― |